Flare Therapeutics

Illuminating the Path to the Possible

Latest funding

$85M Series B+ · June 30, 2026

Total raised: $167M across 2 sourced rounds

Website: flaretx.com.

LinkedIn: flare-therapeutics.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Health Care, Life Science, Neuroscience.

Stage: Series B+.

Based in: Cambridge, United States.

Founded: 2021.

Total raised: $167M in 2 sourced rounds.

Last round: Jun 30, 2026 · 138 days ago.

Headcount: 51–100 employees.

On Recent Funding since: Sep 29, 2026.

Signals

Website registeredOct 28, 2020 (6 years old)

TIMELINE · MONEY RAISED

Raised $167M in 2 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Date	Round	Amount	Lead	Source
Jun 30, 2026	Series B+	$85M	NNextech Invest	fundraisingfox.com
Mar 22, 2023	Series B+	undisclosed	GGordonMD Global Investments	prnewswire.com
May 13, 2021	Series A	$82M	TThird Rock Ventures	businesswire.com

FR
Fraydoon Rastinejad Founder
ML
Mitchell Lazar Founder

LinkedIn
RS
Robert Sims Chief Scientific Officer and Co-Founder

LinkedIn · source: flaretx.com
SM
STEVE MCKNIGHT Founder

LinkedIn · also Nura Bio
AP
Anna Protopapas CEO
BD
Brian DeSchuytner Chief Financial Officer & Chief Business Officer
DM
Doug Manion Chief Executive Officer
JW
Jeanette W. Kohlbrenner Interim Chief People Officer
MB
Michaela Bowden SVP, Biology & Translation
SE
Stephen Eck Chief Medical Officer

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/flare-therapeutics (get a free API key).